Variant report
Variant | nsv1021507 |
---|---|
Chromosome Location | chr5:119224343-119280591 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:119278619..119279545-chr5:119793318..119794660,3 | MCF-7 | breast: | |
2 | chr5:119278671..119279490-chr5:119662851..119663369,2 | MCF-7 | breast: | |
3 | chr2:185990403..185991343-chr5:119236365..119236898,2 | MCF-7 | breast: | |
4 | chr18:65208157..65208941-chr5:119229771..119230382,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184627428 | chr5:119228006-119228007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561926837 | chr5:119228062-119228063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530444406 | chr5:119228124-119228125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533290611 | chr5:119228138-119228139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189459426 | chr5:119228148-119228149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs36123705 | chr5:119228150-119228151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374492156 | chr5:119228159-119228160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148471737 | chr5:119228196-119228197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs180716691 | chr5:119228200-119228201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552541550 | chr5:119228224-119228225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142696871 | chr5:119228234-119228235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534854640 | chr5:119228238-119228239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560143713 | chr5:119228248-119228249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147562390 | chr5:119228252-119228253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574770889 | chr5:119228273-119228274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537086977 | chr5:119228281-119228282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557316845 | chr5:119228282-119228283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577316891 | chr5:119228285-119228286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527702133 | chr5:119228321-119228322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546285345 | chr5:119228409-119228410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142003676 | chr5:119228421-119228422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145852046 | chr5:119228425-119228426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542015613 | chr5:119228434-119228435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561988791 | chr5:119228514-119228515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530816652 | chr5:119228542-119228543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186047351 | chr5:119228548-119228549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564105577 | chr5:119228596-119228597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191069662 | chr5:119228605-119228606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181831706 | chr5:119228607-119228608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs368912789 | chr5:119228640-119228641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs371570384 | chr5:119228694-119228695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566202397 | chr5:119228696-119228697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375030539 | chr5:119228713-119228714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367705047 | chr5:119228719-119228720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568442710 | chr5:119228720-119228721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185933390 | chr5:119228733-119228734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114668603 | chr5:119228751-119228752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115258208 | chr5:119228752-119228753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147804591 | chr5:119228761-119228762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557327522 | chr5:119228801-119228802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549998391 | chr5:119228849-119228850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2973963 | chr5:119228851-119228852 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs11241518 | chr5:119228879-119228880 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
44 | rs552831491 | chr5:119228921-119228922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73251893 | chr5:119228983-119228984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs553924162 | chr5:119229093-119229094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542078796 | chr5:119229119-119229120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs141248705 | chr5:119229154-119229155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs190388582 | chr5:119229218-119229219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565642769 | chr5:119229219-119229220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:119228000-119228200 | Enhancers | Skeletal Muscle Male | skeletal muscle |
2 | chr5:119228200-119228800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
3 | chr5:119228600-119229000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr5:119229000-119233000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr5:119229600-119229800 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:119232200-119232400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
7 | chr5:119232200-119233200 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:119232400-119232800 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
9 | chr5:119232400-119233600 | Enhancers | Rectal Mucosa Donor 29 | rectum |
10 | chr5:119232800-119233800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
11 | chr5:119233000-119233800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr5:119233800-119234400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr5:119249000-119249400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
14 | chr5:119249400-119249800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr5:119249400-119250000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr5:119249600-119250000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr5:119264600-119264800 | Active TSS | Gastric | stomach |
18 | chr5:119264800-119265000 | Enhancers | Aorta | Aorta |
19 | chr5:119264800-119266400 | Weak transcription | Gastric | stomach |